May 2009 Volume 43 Number 9, pp 669 - 743
---------------------------------------------------------------------
Attending the ASCO Annual Meeting in Orlando, FL this month?
http://links.ealert.nature.com/ctt?kn=54&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Visit us at Booth 1563 to meet the Editors and pick up your
complimentary copy of Nature Reviews Clinical Oncology and other
related journals from Nature Publishing Group.
We hope to see you there!
http://links.ealert.nature.com/ctt?kn=35&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=20&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
to start your subscription today.
----------------------
REVIEW
----------------------
Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT
G Kobbe, I Bruns, R Fenk, A Czibere and R Haas
Abstract: http://links.ealert.nature.com/ctt?kn=10&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=67&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Delay in B-lymphocyte recovery and function following rituximab for
EBV-associated lymphoproliferative disease early post-allogeneic
hematopoietic SCT
K Masjosthusmann, K Ehlert, B R Eing, J Roth, G Koehler, H Juergens,
M Fruehwald and A H Groll
Abstract: http://links.ealert.nature.com/ctt?kn=72&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=45&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT
for AML
R M Saliba, K V Komanduri, S Giralt, J de Souza, P Patah, B Oran,
D Couriel, G Rondon, R E Champlin and M de Lima
Abstract: http://links.ealert.nature.com/ctt?kn=27&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
HLA-E upregulation on IFN-[gamma]-activated AML blasts impairs
CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic
SCT
S Nguyen, V Beziat, N Dhedin, M Kuentz, J P Vernant, P Debre and
V Vieillard
Abstract: http://links.ealert.nature.com/ctt?kn=66&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=73&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Rituximab purging and maintenance combined with auto-SCT: long-term
molecular remissions and prolonged hypogammaglobulinemia in relapsed
follicular lymphoma
L K Hicks, A Woods, R Buckstein, J Mangel, N Pennell, L Zhang, K Imrie,
D Spaner, M C Cheung, A Boudreau, M Reis, M Crump and N L Berinstein
Abstract: http://links.ealert.nature.com/ctt?kn=57&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=7&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Alemtuzumab markedly reduces chronic GVHD without affecting overall
survival in reduced-intensity conditioning sibling allo-SCT for adults
with AML
R K Malladi, A J Peniket, T J Littlewood, K E Towlson, R Pearce,
J Yin, J D Cavenagh, C Craddock, K H Orchard, E Olavarria, G McQuaker,
M Collin and D I Marks
Abstract: http://links.ealert.nature.com/ctt?kn=23&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate
mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk:
an observational cohort study
M Schleuning, D Judith, Z Jedlickova, T Stubig, M Heshmat, H Baurmann and
R Schwerdtfeger
Abstract: http://links.ealert.nature.com/ctt?kn=34&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=41&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
A randomized trial on the effect of a multimodal intervention on physical
capacity, functional performance and quality of life in adult patients
undergoing allogeneic SCT
M Jarden, M T Baadsgaard, D J Hovgaard, E Boesen and L Adamsen
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Successful combination treatment with bevacizumab, thalidomide and autologous
PBSC for severe POEMS syndrome
C Ohwada, C Nakaseko, S Sakai, Y Takeda, D Abe, M Takeuchi, E Sakaida,
S Masuda, N Shimizu, R Cho, M Nishimura, K Kanai, S Misawa and S Kuwabara
http://links.ealert.nature.com/ctt?kn=16&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
Strongyloides stercoralis hyperinfection after allogeneic stem cell
transplantation
F L Dulley, S Costa, R Cosentino, C Gamba and R Saboya
http://links.ealert.nature.com/ctt?kn=50&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
----------------------
CORRIGENDUM
----------------------
Are there roles for observational database studies and structured
quantification of expert opinion to answer therapy controversies
in transplants?
R P Gale, M Eapen, B Logan, M-J Zhang and H M Lazarus
http://links.ealert.nature.com/ctt?kn=69&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
---------------------------------------------------------------------
Transplantation Immunobiology
brought to you by Immunology & Cell Biology
Immunology & Cell Biology
http://links.ealert.nature.com/ctt?kn=31&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
presents Transplantation Immunobiology - a limited time special issue
highlighting the two greatest challenges facing the widespread use of
transplanted organs and the two approaches used to overcome these
problems. The accompanying web focus also dives into various techniques
available for preventing transplantable organ rejection.
Explore what Transplantation Immunobiology has to offer today!
http://links.ealert.nature.com/ctt?kn=43&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=24&m=32921285&r=MTc1NjE0NTQ4OQS2&b=2&j=NDk0Njg5OTIS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
